Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
9.93
-0.17 (-1.73%)
At close: Jul 30, 2025, 4:00 PM
10.00
+0.07 (0.76%)
After-hours: Jul 30, 2025, 5:06 PM EDT

Elicio Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Selling, General & Admin
11.6111.3311.95.637.543
Upgrade
Research & Development
33.8833.6623.8518.117.9312.72
Upgrade
Operating Expenses
45.4844.9935.7523.7325.4715.72
Upgrade
Operating Income
-45.48-44.99-35.75-23.73-25.47-15.72
Upgrade
Interest Expense
-0.6-0.46-1.06-3.6-0.88-
Upgrade
Interest & Investment Income
0.840.780.370.0700.01
Upgrade
Currency Exchange Gain (Loss)
-00.150.2---
Upgrade
Other Non Operating Income (Expenses)
-6.04-7.390.43-0.95-0.05-
Upgrade
EBT Excluding Unusual Items
-51.28-51.9-35.8-28.21-26.4-15.71
Upgrade
Gain (Loss) on Sale of Assets
-0----
Upgrade
Other Unusual Items
--0.610--
Upgrade
Pretax Income
-51.28-51.9-35.2-28.21-26.4-15.71
Upgrade
Net Income
-51.28-51.9-35.2-28.21-26.4-15.71
Upgrade
Net Income to Common
-51.28-51.9-35.2-28.21-26.4-15.71
Upgrade
Shares Outstanding (Basic)
1312501511
Upgrade
Shares Outstanding (Diluted)
1312501511
Upgrade
Shares Change (YoY)
70.64%141.35%1500.08%-97.93%42.39%172.21%
Upgrade
EPS (Basic)
-3.98-4.25-6.96-89.27-1.73-1.46
Upgrade
EPS (Diluted)
-3.98-4.25-6.96-89.27-1.73-1.46
Upgrade
Free Cash Flow
-35.15-37.16-32.76-22.83-24.46-16.9
Upgrade
Free Cash Flow Per Share
-2.73-3.04-6.48-72.26-1.60-1.57
Upgrade
EBITDA
-45.19-44.67-35.36-23.34-25.22-15.53
Upgrade
D&A For EBITDA
0.290.320.380.390.250.19
Upgrade
EBIT
-45.48-44.99-35.75-23.73-25.47-15.72
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q